ClinicalTrials HQ

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

Recruiting · NCT04617522 · Registry updated 2026-06-02
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver ImpairmentDigestive System Diseases, Hepatic Insufficiency, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, liver disorder, liver failure, neoplasmRecruitingPhase 12026-06-02NCT04617522

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Gilead Sciences180

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Leon BerardLyonFrance70
Christiana Care Health ServicesNewarkUnited States7
Hospital Universitario Virgen del RocíoSevilleSpain68
Institut Bergonie Medical OncologyBordeauxFrance1
Institut Català d'Oncologia - L'Hospitalet de LlobregatBarcelonaSpain1
Institut de Cancerologie de l'Ouest (ICO) - Saint-HerblainSaint-HerblainFrance1
Instituto Europeo di OncologiaMilanItaly9
Istituto Nazionale Tumori IRCCS Fondazione G. PascaleNaplesItaly12
NEXT AustinAustinUnited States10
NEXT OncologySan AntonioUnited States70
Oncology Consultants, P.A.HoustonUnited States9
Pacific Shores Medical GroupLong BeachUnited States4
Texas Liver InstituteSan AntonioUnited States5
The University of Texas M.D. Anderson Cancer CenterHoustonUnited States18
University of MarylandBaltimoreUnited States86